Literature DB >> 28764553

Severe infections and subsequent delayed cardiovascular disease.

Cecilia Bergh1, Katja Fall1, Ruzan Udumyan1, Hugo Sjöqvist1, Ole Fröbert2, Scott Montgomery1,3,4.   

Abstract

Background Severe infections in adulthood are associated with subsequent short-term cardiovascular disease. Whether hospital admission for sepsis or pneumonia is associated with persistent increased risk (over a year after infection) is less well established. Design The design of this study was as a register-based cohort study. Methods Some 236,739 men born between 1952-1956 were followed from conscription assessments in adolescence to 2010. All-cause cardiovascular disease ( n = 46,754), including coronary heart disease ( n = 10,279) and stroke ( n = 3438), was identified through national registers 1970-2010 (at ages 18-58 years). Results Sepsis or pneumonia in adulthood (resulting in hospital admission) are associated with increased risk of cardiovascular disease in the years following infection. The risk is highest during the first year after the infection, with an adjusted hazard ratio (and 95% confidence intervals) of 6.33 (5.65-7.09) and a notably increased risk persisted with hazard ratios of 2.47 (2.04-3.00) for the second and 2.12 (1.71-2.62) for the third year after infection. The risk attenuated with time, but remained raised for at least five years after infection; 1.87 (1.47-2.38). The results are adjusted for characteristics in childhood, cardiovascular risk factors and medical history in adolescence. Similar statistically significant associations were found for coronary heart disease and stroke. Conclusions Raised risks of cardiovascular disease following hospital admission for sepsis or pneumonia were increased for more than five years after the infection, but with the highest magnitude during the first three years following infection, suggesting a period of vulnerability when health professionals and patients should be aware of the heightened risk for cardiovascular disease.

Entities:  

Keywords:  Adult infection; cardiovascular disease; risk factors; sepsis; stroke pneumonia

Mesh:

Year:  2017        PMID: 28764553     DOI: 10.1177/2047487317724009

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  15 in total

Review 1.  Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?

Authors:  Alan Kaplan; Pierre Arsenault; Brian Aw; Vivien Brown; George Fox; Ron Grossman; Taj Jadavji; Craig Laferrière; Suzanne Levitz; Mark Loeb; Andrew McIvor; Christopher H Mody; Yannick Poulin; Marla Shapiro; Dominique Tessier; Francois Théorêt; Karl Weiss; John Yaremko; George Zhanel
Journal:  Can Fam Physician       Date:  2019-09       Impact factor: 3.275

2.  Wearable Photoplethysmography for Cardiovascular Monitoring.

Authors:  Peter H Charlton; Panicos A Kyriaco; Jonathan Mant; Vaidotas Marozas; Phil Chowienczyk; Jordi Alastruey
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2022-03-11       Impact factor: 10.961

3.  Early life infection and proinflammatory, atherogenic metabolomic and lipidomic profiles in infancy: a population-based cohort study.

Authors:  Toby Mansell; Richard Saffery; Satvika Burugupalli; Anne-Louise Ponsonby; Mimi L K Tang; Martin O'Hely; Siroon Bekkering; Adam Alexander T Smith; Rebecca Rowland; Sarath Ranganathan; Peter D Sly; Peter Vuillermin; Fiona Collier; Peter Meikle; David Burgner
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

Review 4.  Obesity, Cardiovascular Disease, and Influenza: How Are They Connected?

Authors:  Lucia Gutiérrez-Spillari; Geovani Palma M; Jorge Aceituno-Melgar
Journal:  Curr Trop Med Rep       Date:  2020-07-06

5.  Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI): study protocol for a randomized, double-blind, placebo-controlled trial.

Authors:  Cecilia Bergh; Rikard Landberg; Kristina Andersson; Lovisa Heyman-Lindén; Ana Rascón; Anders Magnuson; Payam Khalili; Amra Kåregren; Johan Nilsson; Carlo Pirazzi; David Erlinge; Ole Fröbert
Journal:  Trials       Date:  2021-05-10       Impact factor: 2.279

6.  Prevalence and Course of Frailty in Survivors of Critical Illness.

Authors:  Nathan E Brummel; Timothy D Girard; Pratik P Pandharipande; Jennifer L Thompson; Ryan T Jarrett; Rameela Raman; Christopher G Hughes; Mayur B Patel; Alessandro Morandi; Thomas M Gill; E Wesley Ely
Journal:  Crit Care Med       Date:  2020-10       Impact factor: 9.296

7.  Hidden hospital mortality in patients with sepsis discharged from the intensive care unit.

Authors:  Inês Aguiar-Ricardo; Hélia Mateus; João Gonçalves-Pereira
Journal:  Rev Bras Ter Intensiva       Date:  2019-06-10

Review 8.  Cardiovascular Events After Community-Acquired Pneumonia: A Global Perspective with Systematic Review and Meta-Analysis of Observational Studies.

Authors:  António Tralhão; Pedro Póvoa
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

Review 9.  Trained Immunity and Reactivity of Macrophages and Endothelial Cells.

Authors:  Charles Drummer; Fatma Saaoud; Ying Shao (邵颖); Yu Sun (孙宇); Keman Xu (徐克曼); Yifan Lu (路一凡); Dong Ni (倪栋); Diana Atar; Xiaohua Jiang (蒋晓华); Hong Wang (王虹); Xiaofeng Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-31       Impact factor: 8.311

10.  Vital Signs: Recent Trends in Stroke Death Rates - United States, 2000-2015.

Authors:  Quanhe Yang; Xin Tong; Linda Schieb; Adam Vaughan; Cathleen Gillespie; Jennifer L Wiltz; Sallyann Coleman King; Erika Odom; Robert Merritt; Yuling Hong; Mary G George
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-09-08       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.